Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

被引:0
作者
Xiao-hui Li
Chong-yu Zhao
En-liang Zhou
Xiao-jun Lin
机构
[1] Collaborative Innovation Center for Cancer Medicine,Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China
[2] Sun Yat-sen University Cancer Center,undefined
来源
BMC Cancer | / 22卷
关键词
Adjuvant chemotherapy; Adverse reactions; Efficacy; Intrahepatic cholangiocarcinoma; Survival analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 87 条
[1]  
Zheng RS(2019)Analysis of the prevalence of malignant tumors in China in 2015 Chin J Oncol 01 19-28
[2]  
Sun KX(2020)Primary liver cancer diagnosis and treatment standards (2019 edition) Chin J Pract Surg 40 121-38
[3]  
Zhang SW(2019)Intrahepatic Cholangiocarcinoma: continuing challenges and translational advances Hepatology. 69 1803-1815
[4]  
Sirica AE(2020)Liver resection and transplantation for intrahepatic cholangiocarcinoma J Hepatol 72 364-377
[5]  
Gores GJ(2019)Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline J Clin Oncol 37 1015-1027
[6]  
Groopman JD(2021)Hepatobiliary Cancers, Version 2. 2021, NCCN Clinical Practice Guidelines in Oncology J Natl Compr Canc Netw 19 541-565
[7]  
Mazzaferro V(2017)The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis J Cancer Res Clin Oncol 143 1347-1355
[8]  
Gorgen A(2017)Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis HPB (Oxford) 19 901-909
[9]  
Roayaie S(2015)Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution Surgery 157 666-675
[10]  
Shroff RT(2018)Surgical Management of Intrahepatic Cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on Peri-operative outcomes World J Surg 42 2551-2560